
Daun-Marisan Pharma Private Limited
About Daun-Marisan Pharma Private Limited
Data last updated:
Daun-Marisan Pharma Private Limited is a private limited company based in Ganga Khera, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2013PTC058914. Its GSTIN is 09AAECD7646L1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Devendra Srivastava and Kapil Srivastava.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 555Ka/280G, Ganga Khera, Uttar Pradesh, India – 226011.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.76 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5,640 (net margin -0.6%) and EBITDA of ₹77,876 (EBITDA margin 8.9%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Daun-Marisan Pharma Private Limited's registered office is in Ganga Khera, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address555Ka/280G, Ganga Khera, Uttar Pradesh, India – 226011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Daun-Marisan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Daun-Marisan Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Daun-Marisan Pharma Private Limited, buy the company report.
Financials of Daun-Marisan Pharma Private Limited
FY 2021 filings availableDaun-Marisan Pharma Private Limited reported revenue of ₹8.76 Lakh (up 180% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 180% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,876 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,640 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daun-Marisan Pharma Private Limited, buy the company report.
Board of directors of Daun-Marisan Pharma Private Limited
Daun-Marisan Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Srivastava | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Kapil Srivastava | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Ashwani Kumar Srivastava | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Daun-Marisan Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ropoz Lifesciences Private Limited | ₹8.85 Lakh (FY 2025) | -86.0% | Ambala, Haryana, India | |||
| Glysan Health Care Private Limited | ₹8.84 Lakh (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Leiwen Pharmaura Private Limited | ₹8.79 Lakh (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Daun-Marisan Pharma Private Limitedthis company | ₹8.76 Lakh (FY 2021) | -₹5,640 | -0.6% | 180.0% | Ganga Khera, Uttar Pradesh, India | |
| Bsa Marketing Private Limited | ₹8.76 Lakh (FY 2025) | -94.0% | Ahmedabad, Gujarat, India | |||
| Floraison Services Private Limited | ₹8.7 Lakh (FY 2024) | -4.0% | New Delhi, Delhi, India | |||
| Vagakem Pharmaceuticals Private Limited | ₹8.64 Lakh (FY 2024) | -8.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Daun-Marisan Pharma Private Limited, buy the company report.
Auditor
Daun-Marisan Pharma Private Limited is audited by G P GUPTA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P GUPTA & CO | FY 2018 | 004998C |
Shareholding
The shareholding of Daun-Marisan Pharma Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Daun-Marisan Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Oct 2013 | 10458750 | State Bank of Hyderabad | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Daun-Marisan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daun-Marisan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daun-Marisan Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECD7646L1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Daun-Marisan Pharma Private Limited, buy the company report.
Recent activity
Daun-Marisan Pharma Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Ashwani Kumar Srivastava was appointed as Director on 12 Aug 2013.
Frequently asked questions
Daun-Marisan Pharma is an active private limited company based in Ganga Khera, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 2013 (13+ years old) and is registered under CIN U74120UP2013PTC058914.
Daun-Marisan Pharma has 3 current directors:
- Devendra Srivastava - Director
- Kapil Srivastava - Director
- Ashwani Kumar Srivastava - Director
The latest financial statements of Daun-Marisan Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Daun-Marisan Pharma is 09AAECD7646L1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Daun-Marisan Pharma is U74120UP2013PTC058914. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daun-Marisan Pharma was incorporated on 12 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Daun-Marisan Pharma by revenue are Ropoz Lifesciences Private Limited, Glysan Health Care Private Limited, Leiwen Pharmaura Private Limited, Bsa Marketing Private Limited, Floraison Services Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ashwani Kumar Srivastava was appointed as Director on 12 Aug 2013. Devendra Srivastava was appointed as Director on 12 Aug 2013. Kapil Srivastava was appointed as Director on 12 Aug 2013.
The registered office of Daun-Marisan Pharma is at 555Ka280G, Ganga Khera, Uttar Pradesh, India – 226011.
Daun-Marisan Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Daun-Marisan Pharma has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

